Compare ZLAB & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | LMAT |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2017 | 2006 |
| Metric | ZLAB | LMAT |
|---|---|---|
| Price | $17.60 | $85.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $57.22 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 1.0M | 211.9K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | N/A | ★ 27.40 |
| EPS | N/A | ★ 2.32 |
| Revenue | ★ $441,629,000.00 | $240,866,000.00 |
| Revenue This Year | $30.20 | $15.17 |
| Revenue Next Year | $34.71 | $9.07 |
| P/E Ratio | ★ N/A | $36.62 |
| Revenue Growth | ★ 24.14 | 13.07 |
| 52 Week Low | $16.82 | $71.42 |
| 52 Week High | $44.34 | $105.55 |
| Indicator | ZLAB | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 29.21 | 54.29 |
| Support Level | $16.82 | $82.52 |
| Resistance Level | $18.29 | $87.09 |
| Average True Range (ATR) | 0.60 | 2.49 |
| MACD | 0.17 | 0.38 |
| Stochastic Oscillator | 24.41 | 64.86 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.